64
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Optimal Glycated Hemoglobin Cutoff for Diagnosis of Diabetes and Prediabetes in Chinese Breast Cancer Women

, , , , , , , , , , & ORCID Icon show all
Pages 1807-1822 | Received 26 Feb 2024, Accepted 24 Apr 2024, Published online: 05 May 2024

Figures & data

Table 1 Characteristics of Chinese Breast Cancer Patients

Figure 1 Flowchart shows participants in this study.

Figure 1 Flowchart shows participants in this study.

Figure 2 Changes in plasma glucose (A) and insulin (B) concentrations during the OGTT and IRT in Chinese breast cancer women with NGT (red), prediabetes (blue) and NDD (black), respectively. Plasma glucose (C) and insulin (D) concentrations for different insulin patterns in the NGT, prediabetes, and NDD groups, respectively. Indices for β-cell function (E) and insulin sensitivity (F) during the OGTT in Chinese breast cancer women with NGT, prediabetes and NDD, respectively. NGT1: NGT patients with a peak of insulin during an IRT at 30 or 60 min; NGT2: NGT patients with peak of insulin at 120 min; Prediabetes1: prediabetes patients with peak of insulin at 30 or 60 min; Prediabetes2: prediabetes patients with peak of insulin at 120 min; NDD1: NDD patients with peak of insulin at 30 or 60 min; NDD2: NDD patients with peak of insulin at 120 min.

Figure 2 Changes in plasma glucose (A) and insulin (B) concentrations during the OGTT and IRT in Chinese breast cancer women with NGT (red), prediabetes (blue) and NDD (black), respectively. Plasma glucose (C) and insulin (D) concentrations for different insulin patterns in the NGT, prediabetes, and NDD groups, respectively. Indices for β-cell function (E) and insulin sensitivity (F) during the OGTT in Chinese breast cancer women with NGT, prediabetes and NDD, respectively. NGT1: NGT patients with a peak of insulin during an IRT at 30 or 60 min; NGT2: NGT patients with peak of insulin at 120 min; Prediabetes1: prediabetes patients with peak of insulin at 30 or 60 min; Prediabetes2: prediabetes patients with peak of insulin at 120 min; NDD1: NDD patients with peak of insulin at 30 or 60 min; NDD2: NDD patients with peak of insulin at 120 min.

Table 2 Characteristics of Chinese Breast Cancer Patients Stratified by the Time of Peak Insulin Secretion

Table 3 Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value, Positive Likelihood Ratio, Negative Likelihood Ratio, and Youden’s Index of HbA1c Cutoff Values for Diabetes

Table 4 Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value, Positive Likelihood Ratio, Negative Likelihood Ratio, and Youden’s Index of HbA1c Cutoff Values for Prediabetes

Figure 3 (A) ROC curve analysis of the performance of HbA1c in predicting diabetes in Chinese women with breast cancer. The AUC was 0.903 (P<0.001, 95% CI, 0.867–0.938). For cutoff point of HbA1c≥6.0%, the sensitivity was 78.1%, and the specificity was 76.9%. (B) ROC curve analysis of the performance of HbA1c in predicting prediabetes in Chinese women with breast cancer. The AUC was 0.703 (P<0.001, 95% CI, 0.632–0.774). For cutoff point of HbA1c≥5.5%, the sensitivity was 76.9%, and the specificity was 51.8%. 5.5%: HbA1c cutoff point for prediabetes found in this study. 5.7%: HbA1c cutoff point for prediabetes recommended by ADA. 6.0%: HbA1c cutoff point for diabetes found in this study. 6.5%: HbA1c cutoff point for diabetes recommended by the ADA.

Abbreviations: ADA, American Diabetes Association; AUC, area under the curve; CI, confidence interval; HbA1c, glycated hemoglobin; ROC, receiver operating characteristic.
Figure 3 (A) ROC curve analysis of the performance of HbA1c in predicting diabetes in Chinese women with breast cancer. The AUC was 0.903 (P<0.001, 95% CI, 0.867–0.938). For cutoff point of HbA1c≥6.0%, the sensitivity was 78.1%, and the specificity was 76.9%. (B) ROC curve analysis of the performance of HbA1c in predicting prediabetes in Chinese women with breast cancer. The AUC was 0.703 (P<0.001, 95% CI, 0.632–0.774). For cutoff point of HbA1c≥5.5%, the sensitivity was 76.9%, and the specificity was 51.8%. 5.5%: HbA1c cutoff point for prediabetes found in this study. 5.7%: HbA1c cutoff point for prediabetes recommended by ADA. 6.0%: HbA1c cutoff point for diabetes found in this study. 6.5%: HbA1c cutoff point for diabetes recommended by the ADA.

Table 5 Agreement Between HbA1c and Glucose Criteria by ADA and Our Research

Table 6 The Cutoff Points of HbA1c for Diagnosing Diabetes and Prediabetes in Different Subgroups

Data Sharing Statement

The datasets used in this study are available on request from the corresponding author.